Skip to content

SCHEDULE 13D/AAccepted Jan 6, 9:00 AM ET

Revance Therapeutics, Inc. SCHEDULE 13D/A

Teoxane SA

sec.gov(opens the filing on sec.gov)

Accepted (ET)

9:00 AM

Jan 6, 2025

Filed

Jan 6, 2025

Documents

4

Size

41.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.